Vodis tenant producing high-THC marijuana VODIS PRODUCTION AND PROCESSING FACILITY DELIVERING HIGH QUALITY PRODUCT TO THE WASHINGTON STATE MARKET; REPETITIVE PRODUCTION OF RECREATIONAL MARIJUANA IS IN FULL CYCLE
Vodis Pharmaceuticals Inc. and its wholly owned subsidiary, Vodis USA Inc., a Washington corporation, have received notice from Vodis's tenant, a licensed Washington State company conducting a recreational marijuana production and processing business, that it has successfully completed, produced and processed several production cycles of multiple strains such as Chem Dawg, Crit Jack and Malawi (34.2 per cent THC-A (tetrahydrocannabinolic acid)) with total cannabinoid counts above 30 per cent. All of the tenant's production lots were tested by a third party Washington State-approved laboratory and has confirmed cannabinoid counts. The tenant, using the turnkey indoor grow facility designed, engineered and built by Vodis, is now entering into a repetitive production mode and is looking to increase capacity in light of the successful production cycles.
Otto Folprecht, chief executive officer and director of Vodis Pharmaceuticals, stated, "This is another important milestone in the growth of our company as we have proven that our turnkey solution and the supporting business processes are capable of producing, on a large scale, high-grade marijuana with exceptionally high cannabinoid counts above 30 per cent." Furthermore, the tenant has advised the company that it has begun shipping replenishment orders to the Bellingham and Seattle market and that the tenant's staff is working with the recreational stores to establish repetitive purchase orders to create a consistent supply chain for the tenant's products.